Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Monotherapy in rheumatoid arthritis

P Emery1

  • 1Department of Rheumatology, University of Birmingham, Edgbaston.

British Journal of Rheumatology
|March 1, 1993
PubMed
Summary

Current rheumatoid arthritis (RA) treatments are debated, with many advocating multi-drug approaches. This review examines the evidence and proposes using prognostic indicators for personalized, aggressive therapy in non-responsive RA patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repeatability of quantitative MRI in patients with rheumatoid arthritis.

Radiography (London, England : 1995)·2022
Same author

Quantitative MRI in myositis patients: comparison with healthy volunteers and radiological visual assessment.

Clinical radiology·2020
Same author

MRI in acute muscle tears in athletes: can quantitative T2 and DTI predict return to play better than visual assessment?

European radiology·2020
Same author

Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis.

Scandinavian journal of rheumatology·2020
Same author

Comparative effectiveness of improvement in pain and physical function for baricitinib versus adalimumab, tocilizumab and tofacitinib monotherapies in rheumatoid arthritis patients who are naïve to treatment with biologic or conventional synthetic disease-modifying antirheumatic drugs: a matching-adjusted indirect comparison.

RMD open·2020
Same author

Differential CpG DNA methylation in peripheral naïve CD4<sup>+</sup> T-cells in early rheumatoid arthritis patients.

Clinical epigenetics·2020

Area of Science:

  • Rheumatology
  • Clinical Medicine
  • Pharmacology

Background:

  • Significant debate exists regarding optimal therapy for rheumatoid arthritis (RA).
  • Current therapeutic strategies, often involving multiple drugs, are questioned.
  • Assumptions about inadequate current therapy necessitate a re-evaluation of RA treatment approaches.

Purpose of the Study:

  • To review the evidence underpinning current RA treatment debates.
  • To advocate for a more discriminating therapeutic approach in RA management.
  • To identify patients with persistent, unresponsive RA for whom aggressive therapy is warranted.

Main Methods:

  • Review of existing evidence on RA therapy.
  • Analysis of arguments for multi-drug RA treatment.
  • Development of a proposal for a personalized treatment strategy based on prognostic indicators.

Main Results:

  • Evidence supporting current assumptions about inadequate RA therapy is critically examined.
  • A subset of RA patients with persistent, unresponsive disease and poor prognosis is identified.
  • The need for a more selective application of aggressive RA therapies is highlighted.

Conclusions:

  • A blanket multi-drug approach for all RA patients may not be optimal.
  • Prognostic indicators can guide the selection of patients for aggressive RA treatment.
  • Personalized medicine, targeting specific patient subgroups, offers a more rational approach to RA management.

Related Experiment Videos